Sirona Biochem (CVE:SBM) Trading Down 16.7% – Time to Sell?

Shares of Sirona Biochem Corp. (CVE:SBMGet Free Report) dropped 16.7% during trading on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. Approximately 113,000 shares changed hands during trading, an increase of 91% from the average daily volume of 59,069 shares. The stock had previously closed at C$0.06.

Sirona Biochem Price Performance

The firm’s fifty day simple moving average is C$0.06 and its 200-day simple moving average is C$0.06. The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The firm has a market capitalization of C$12.84 million, a PE ratio of -5.00 and a beta of -0.03.

Sirona Biochem Company Profile

(Get Free Report)

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.

Featured Articles

Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.